Longevity Pharma Startup NewLimit Raises $40M in Funding to Extend Human Lifespan
![](data:image/svg+xml;utf-8,<svg xmlns="http://www.w3.org/2000/svg" width="706" height="434" />)
NewLimit, a promising longevity pharma startup co-founded by Brian Armstrong, the CEO of leading crypto exchange Coinbase, has successfully raised $40 million in a Series A funding round. The company, dedicated to extending the human lifespan, announced the funding on Tuesday, with prominent investors such as Dimension, Founders Fund, Kleiner Perkins, Eric Schmidt, Elad Gil, Garry Tan, and Fred Ehrsam participating in the round. NewLimit had previously raised $110 million in 2021 from co-founders Blake Byers and Brian Armstrong. This initial funding, committed over the company’s lifetime, remains ongoing and not yet fully utilized.
3 comments